Tokyo, Japan

Yukio Utsui


Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Tokyo, JP (1994 - 1999)
  • Tokorozawa, JP (2000 - 2007)

Company Filing History:


Years Active: 1994-2007

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Yukio Utsui

Introduction

Yukio Utsui is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 7 patents to his name, Utsui's work has had a considerable impact on medical treatments.

Latest Patents

Utsui's latest patents include an innovative antibacterial compound. This compound is characterized by a specific formula that includes various groups such as aryl, heterocyclic, alkyl, and alkenyl, which may be substituted. The invention also encompasses a pharmaceutical composition that utilizes this compound as an active ingredient for preventing or treating bacterial infections. Additionally, Utsui has developed a method and treatment using 1-methylcarbapenem derivatives as an anti-Helicobacter pylori agent. This method involves administering a pharmacologically effective amount of a 1-methylcarbapenem compound or its acceptable salt or ester to treat infectious diseases.

Career Highlights

Yukio Utsui is associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments for bacterial infections, showcasing his dedication to improving public health.

Collaborations

Utsui has collaborated with notable colleagues such as Satoshi Ohya and Isao Kawamoto. These partnerships have further enhanced the scope and impact of his research and inventions.

Conclusion

Yukio Utsui's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective treatments for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…